The FDA’s Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016

This study uses the Drugs@FDA database to analyze clinical development times for drugs to treat serious diseases within the 4 FDA expedited programs intended to speed drug review and approval.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA
Asıl Yazarlar: Hwang, Thomas J., Darrow, Jonathan J., Kesselheim, Aaron S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2017
Konular:
Research Letter
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820715/
https://ncbi.nlm.nih.gov/pubmed/29209711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.14896
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller